Measles outbreak in South Africa, 2003-2005

South African Medical Journal

Volumn 99, Issue 5, 2009, Pages 314-319

  McMorrow, Meredith L ^a   Gebremedhin, Goitom ^b   van den Heever, Johann ^c   Kezaala, Robert ^b   Harris, Bernice N ^d,e   Nandy, Robin ^f   Strebel, Peter ^b   Jack, Abdoulie ^b   Cairns, K Lisa ^f  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL DEPARTMENT OF HEALTH   (South Africa)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e UNIVERSITY OF PRETORIA   (South Africa)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MEASLES; SCREENING TEST; SOUTH AFRICA; ADULT; CONTACT EXAMINATION; DISEASE TRANSMISSION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DISEASE OUTBREAKS; HIV INFECTIONS; HUMANS; INFANT; MEASLES; MEASLES VACCINE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; YOUNG ADULT;

EID: 67651213909     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Otten M, Kezaala R, Masresha B, et al. Public-health impact of accelerated measles control in the WHO African Region 2000-2003. Lancet 2005; 366: 832-839.
2. Biellik R, Madema S, Taole A, et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002; 359: 1564-1568.
3. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas - evolving strategies. JAMA 1996; 275: 224-229.
4. Department of Health. National HIV and syphilis antenatal sero-prevalence survey in South Africa 2004. Pretoria: Department of Health, 2005. http://www.doh.gov.za/docs/reports/2004/hiv-syphilis.pdf (accessed 14 April 2006).
5. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1992; 11: 1008-1014.
6. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003; 81: 61-70. http://www.who.int/bulletin/Moss0103.pdf (accessed 14 April 2006).
7. World Health Organization. Generic protocol for determining measles case fatality rates in a community, either during an epidemic or in a highly endemic area. WHO document WHO/EPI/GEN/93.3. Geneva: WHO, 1993.
8. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22: 742-746.
9. Centers for Disease Control and Prevention. Outbreak of Measles - Venezuela and Colombia, 2001-2002. MMWR Morb Mortal Wkly Report 2002; 51: 757-760 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5134a1.htm (accessed 14 April 2006).
10. Orenstein WA, Hinman AR, PJ Strebel. Measles: the need for 2 opportunities for prevention [commentary]. Clin Infect Dis 2006; 42: 320-321.
11. Scott S, Cumberland P, Schulman CE, et al. Neonatal measles in rural Kenya: The influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Inf Dis 2005; 191: 1854-1860.
12. D'Souza RM, D'Souza RD. Vitamin A for the treatment of children with measles - a systematic review. J Trop Pediatr 2002; 48: 323-327.
13. Biellik RJ, CJ Clements. Strategies for minimizing nosocomial measles transmission. Bull World Health Organ 1997; 75: 367-375. http://whqlibdoc.who.int/bulletin/1997/Vol75-No4/ bulletin_1997_75(4)_367-375.pdf (accessed 14 April 2006).
14. Nandy R, Handzel T, Zaneidou M, et al. Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis 2006; 42: 322-328.
15. Nolan ML, Greenberg AD, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS 2002; 16: 1991-1999.
16. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 2005; 83: 489-494. http://www.who.int/bulletin/volumes/ 83/7/489.pdf (accessed 14 April 2006).
17. Oshitani H, Suzuki H, Mpabalwani ME, Mitzuta K, Numazaki Y. Measles case fatality by sex, vaccination status and HIV-1 antibody in Zambian children. Lancet 1996; 348: 415.
18. Helfand RF, Moss WJ, Harpaz R, Scott S, Cutts F. Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ 2005; 83: 329-337. http://www.who.int/bulletin/volumes/ 83/5/329.pdf (accessed 14 April 2006).
19. Quiroga R, Barrezueta O, Venczel L, et al. Interruption of indigenous measles transmission in Bolivia since October 2000. J Infect Dis 2003; 187 (suppl 1): S121-126.
20. Pan American Health Organization. Update: Sao Paulo Measles Outbreak. PAHO EPI Newsletter 1998; 20: 5-6. http://www.paho.org/english/ ad/fch/im/sne2001.pdf (accessed 14 April 2006).